Tritherapies in HIV infection : Prospects;Les trithérapies dans l'infection VIH : Espoirs et limites

Medecine et Hygiene

Volumn 55, Issue 2161, 1997, Pages 862-865

  Perrin, L ^a   Schockmel, G ^a   Yerly, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIVIRUS AGENT; BMP 266; DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; TALVIRALINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SHORT SURVEY;

EID: 0030979785     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Gulick R, Mellors J, Havlir D, et al. Potent and sustained antiretroviral activity on indínavir (IDV) in combination with adovudine (ZDV) and lamivudine (3TC). 3rd Conference on Retrovirus and Opportunistic Infection. Washington DC, January 1996 (abstract).
2. Collier AC, Coombs RW, Schoenfeld DA, et al Treatment of human immunodeficiency virus infection with saquinavir, zidouvudine, and zalcitabine. N Engl J Med 1996 ; 334 : 1011-7.
3. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995 ; 373 : 123-6.
4. Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, Fauci AS. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991 ; 88 : 9838-42.
5. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Ann Rev Immunol 1995 ; 13 : 487-512.
6. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993 ; 362 : 359-62.
7. Saag MS, Crain MJ, Decker WD, et al. High-level viremia in adults and children infected with human immunodeficiency virus : Relation to disease stage and CD4+ lymphocyte levels. J Infect Dis 1991 ; 164 : 72-80.
8. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996 ; 272 : 1167-70.
9. Richman DD, Grimes JM, Lagakos SW. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr 1990 ; 3 : 743-6.
10. Hirschel B, Lorenzi P, Yerly S, et al. Escape of viremia and rapid development of protease mutations in advanced HIV infection treated with saquinavir plus ritonavir. 4th Conference on Retroviruses and Opportunistic Infections, Washington, January 1997 ; Abstract.
11. Perelson AS, Essurger P, Markowitz M, Ho DD. How long should treatment be given if we has an anti-retroviral regimen that completely blocks HIV replication ? XI International Conference on AIDS, Vancouver, July 1996 (abstract Th B 930).
12. Perrin L, Yerly S, Charvier A, Figueras G, Schockmel G, Hirschel B. Zidovudine plus didanosine in primary HIV-1 infection. Antiviral Therapy 96. 1997 ; 2 : 9-15.